BIOCORTEX LTD
Company number 13287534 · Active · London W1W 5PF
BIOCORTEX LTD is an active private limited company (company number 13287534) incorporated on 23 March 2021, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 March 2025, showing net assets of −£357k and cash of £401k, with 13 employees on average. Net assets fell 125% on the prior period (£1.42m).
By net assets it sits in the bottom quarter of 603 comparable companies in London (median £440, upper quartile £92k).
Key dates
- Incorporated
- 23 March 2021
- Next accounts due
- 31 December 2026 — in 74 days
- Confirmation statement due
- 6 April 2027 — in 170 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- Micro (Companies Act thresholds)
Financials — 2 periods on record, latest ending 31 March 2025
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | −£357k | £401k | £738k | — | — | — | 13 |
| 31 March 2024 | £1.42m | £583k | £814k | — | — | — | 13 |
- Cash per employee
- £31k
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Firmoscan score: 39/100 (grade D)
- -15 Negative net assets — Net assets £-356,814 at 2025-03-31
- -8 Net assets falling — -125.2% vs prior period
- +4 Cash reserves — Cash £401,299
- +8 Established — Incorporated 2021-03-23 (6 years)
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Biocortex Inc. (corporate entity, United States) — owns 75–100% of shares; holds 75–100% of voting rights · since 23 May 2023
- Mr Muhannad Al-Omari — owns 25–50% of shares; holds 25–50% of voting rights; can appoint or remove directors · since 23 March 2021 · ceased 23 May 2023
- Dr Nikhil Sharma — owns 25–50% of shares; holds 25–50% of voting rights; can appoint or remove directors · since 23 March 2021 · ceased 23 May 2023
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in London
Same activity (research and experimental development on biotechnology), closest in incorporation date.
- RQ BIOTECHNOLOGY LIMITED — London, inc. Mar 2021
- POOLBEG PHARMA (UK) LIMITED — London, inc. Mar 2021
- POOLBEG PHARMA PLC — London, inc. Mar 2021
- DIOME LIMITED — London, inc. Mar 2021
- NANOCLONE LIFE SCIENCES LTD — London, inc. Mar 2021
- HCON ELEMENTS LIMITED — London, inc. Mar 2021
Reminders for BIOCORTEX LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.